PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, Wuhan University School of Pharmaceutical Sciences, Wuhan University, Wuhan, China.\', \'Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts.\', \'Department of anatomy, School of Basic Medical Sciences, Wuhan University, Wuhan, China.\', \'Department of Respiratory Diseases, The Second Affiliated Hospital of Nanchang University, Nanchang, China.\', \'Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts.\', \'Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, Louisiana.\', \'Department of Microbiology & Immunology, College of Veterinary Medicine, Cornell University, Ithaca, New York.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/jmv.26064
?:hasPublicationType
?:journal
  • Journal of medical virology
is ?:pmid of
?:pmid
?:pmid
  • 32458502
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.978
?:rankingScore_hIndex
  • 105
is ?:relation_isRelatedTo_publication of
?:title
  • Glycyrrhetinic acid and its derivatives as potential alternative medicine to relieve symptoms in nonhospitalized COVID-19 patients.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32458502>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32458502>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all